Application of four pricing models for orphan medicines: a case study for lumasiran
{{output}}
Background: The combination of high prices and uncertain effectiveness is a growing challenge in the field of orphan medicines, hampering health technology assessments. Hence, new methods for establishing price benchmarks might b... ...
